Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials

BMC Endocrine Disorders

Michaela Eikermann¹  Tim Mathes¹  Dawid Pieper¹  Sunya-Lee Antoine¹ 

[1] Institute for Research in Operative Medicine, Faculty of Health - School of Medicine, Witten/Herdecke University, Ostmerheimer Str. 200, Building 38, D- 51109 Cologne, Germany

关键词: Systematic review;    Type 2 diabetes mellitus;    Pharmacist intervention;    Adherence;   

Others  :  863177
DOI  :  10.1186/1472-6823-14-53

 received in 2014-04-28, accepted in 2014-06-30,  发布年份 2014

【 摘 要 】

Background

Oral medication for patients with type 2 diabetes mellitus plays an important role in diabetes care and is associated with a high level self-care behavior and self-management. However, poor adherence to diabetes treatment is common which causes severe health complications and increased mortality. Barriers to adherence may consist of complex treatment regimens often along with long-term multi-therapies, side effects due to the medication as well as insufficient, incomprehensible or confusing information or instructions provided by the health care provider. Multidisciplinary approaches can support adherence success and can enable a more effective management of diabetes care. One approach in diabetes care can be the involvement of a pharmacist. The aim was to analyze the effectiveness of adherence-enhancing pharmacist interventions for oral medication in type 2 diabetes mellitus.

Methods

A systematic review of randomized controlled trials. The study quality was assessed with the Cochrane risk of bias tool.

Results

Of 491 hits, six publications were included. Two studies mainly examining educational interventions showed a significant improvement in adherence. Moreover, the quality of the included studies was deficient.

Conclusion

Although pharmacist interventions might potentially improve adherence to type 2 diabetes mellitus medication, high-quality studies are needed to assess effectiveness.

【 授权许可】

   
2014 Antoine et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]World Health Organisation (WHO): Adherence to Long-Term Therapies-Evidence for action. 2003.
• [2]Cramer JA, Okikawa J, Bellaire S, Clauson P: Compliance with inhaled insulin treatment using the AERx(registered trademark) iDMS insulin diabetes management system. Diab Technol Ther 2004, 6(6):800-807.
• [3]Vermeire EIJJ, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A: Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005, (2):CD003638.
• [4]Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ: Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006, 166(17):1836-1841. PubMed PMID: 17000939. Epub 2006/09/27. eng
• [5]Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M: The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 2012, 35(6):1279-1284. PubMed PMID: 22511257. Pubmed Central PMCID: 3357221. Epub 2012/04/19. eng
• [6]World Health Organisation (WHO): Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999.
• [7]Nam S, Chesla C, Stotts NA, Kroon L, Janson SL: Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract 2011, 93(1):1-9. PubMed PMID: 21382643. Epub 2011/03/09. eng
• [8]Odegard PS, Gray SL: Barriers to medication adherence in poorly controlled diabetes mellitus. Diab Educ 2008, 34(4):692-697.
• [9]Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Giri M: Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Ther 2011, 36(5):602-613.
• [10]Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y: Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther 2006, 31(5):409-419. PubMed PMID: 16958818. Epub 2006/09/09. eng
• [11]Spinewine A, Fialova D, Byrne S: The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging 2012, 29(6):495-510. PubMed PMID: 22642783. Epub 2012/05/31. eng
• [12]Hume AL, Kirwin J, Bieber HL, Couchenour RL, Hall DL, Kennedy AK, LaPointe NM, Burkhardt CD, Schilli K, Seaton T, Trujillo J, Wiggins B: Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy 2012, 32(11):e326-e337. PubMed PMID: 23108810. Epub 2012/10/31. eng
• [13]World Health Organisation (WHO): The Role of the Pharmacist in the Health Care System. 1993.
• [14]Omran D, Guirguis LM, Simpson SH: Systematic review of pharmacist interventions to improve adherence to oral antidiabetic medications in people with type 2 diabetes. Can J Diab 2012, 36(5):292-299.
• [15]Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK: Medication compliance and persistence: terminology and definitions. Value Health 2008, 11(1):44-47.
• [16]Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group: The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928. PubMed PMID: 22008217. Pubmed Central PMCID: 3196245
• [17]Hartling L, Hamm MP, Milne A, Vandermeer B, Santaguida PL, Ansari M, Tsertsvadze A, Hempel S, Shekelle P, Dryden DM: Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol 2013, 66(9):973-981. PubMed PMID: 22981249. Epub 2012/09/18. eng
• [18]Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Seida JK, Klassen TP: Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009, 37(09):339. 2009-10-19 11
• [19]Adepu R, Ari SM: Influence of structured patient education on therapeutic outcomes in diabetes and hypertensive patients. Asian J Pharm Clin Res 2010, 3(3):174-178.
• [20]Grant RW, Devita NG, Singer DE, Meigs JB: Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother 2003, 37(7–8):962-969.
• [21]Obreli-Neto PR, Guidoni CM, De Oliveira BA, Pilger D, Cruciol-Souza JM, Gaeti-Franco WP, Cuman RKN: Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm 2011, 33(4):642-649.
• [22]Odegard PS, Goo A, Hummel J, Williams KL, Gray SL: Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother 2005, 39(3):433-440.
• [23]Phumipamorn S, Pongwecharak J, Soorapan S, Pattharachayakul S: Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes. Prim Care Diab 2008, 2(1):31-37.
• [24]Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, Bermann M, Kerr EA: Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation 2012, 125(23):2863-2872. PubMed PMID: 22570370. Epub 2012/05/10. eng
• [25]Bogner HR, Morales KH, de Vries HF, Cappola AR: Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med 2012, 10(1):15-22. PubMed PMID: 22230826. Pubmed Central PMCID: 3262455
• [26]Chan CW, Siu SC, Wong CK, Lee VW: A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther 2012, 17(1):57-64. PubMed PMID: 21335480
• [27]Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC: Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diab Educ 2011, 37(6):801-812. PubMed PMID: 22021025. Epub 2011/10/25. eng
• [28]Farmer A, Hardeman W, Hughes D, Prevost A, Kim Y, Craven A, Oke J, Boase S, Selwood M, Kellar I, Graffy J, Griffin S, Sutton S, Kinmonth AL: An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Fam Pract 2012, 13(1):1-9. English
• [29]Iram M, Pais N, Rani S: Impact Of Patient Counseling And Education Of Diabetic Patients In Improving Their Quality Of Life 2010. 2010, 18-22.
• [30]Jacobs M, Sherry PS, Taylor LM, Amato M, Tataronis GR, Cushing G: Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. J Am Pharm Assoc 2012, 52(5):613-621. PubMed PMID: 23023841. Epub 2012/10/02. eng
• [31]Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T: Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in jordan. J Manag Care Pharm 2012, 18(7):516-526.
• [32]Planas LG, Crosby KM, Mitchell KD, Farmer KC: Evaluation of a hypertension medication therapy management program in patients with diabetes. JAPhA 2009, 49(2):164-170.
• [33]Ramanath KVYLS: Impact of clinical pharmacist provided patient education on QOL outcome in type II diabetes mellitus in rural population. Asian J Pharma Clin Res 2011, 4(4):15-20.
• [34]Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC: Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol 2009, 67(5):547-557.
• [35]Clifford RM, Batty KT, Davis TME, Davis W, Stein G, Stewart G, Plumridge RJ: A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 2002, 10(2):85-89.
• [36]Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M: Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011, 16(1):43-49.
• [37]Kirwin JL, Cunningham RJ, Sequist TD: Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial. J Manag Care Pharm 2010, 16(2):104-113.
• [38]Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J: The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med 2007, 24(6):677-683.
• [39]Skaer TL, Sclar DA, Markowski DJ, Won JKH: Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993, 18(4):295-299.
• [40]Suppapitiporn S, Chindavijak B, Onsanit S: Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai 2005, 88(Suppl 4):S134-S141.
• [41]Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P: Self-report adherence measures in chronic illness: retest reliability and predictive validity. Med Care 2008, 46(11):1134-1139. PubMed PMID: 18953223. Epub 2008/10/28. eng
• [42]Gonzalez JS, Schneider HE, Wexler DJ, Psaros C, Delahanty LM, Cagliero E, Safren SA: Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care 2013, 36(4):831-837.
• [43]Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC: Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012, 5:CD008165. PubMed PMID: 22592727. Epub 2012/05/18. eng
• [44]Ahmad A, Hugtenburg J, Welschen LM, Dekker JM, Nijpels G: Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial. BMC Public Health 2010, 10:133.
• [45]Tonna APSD, McCaig D: An international overview of some pharmacist prescribing models. J Malta Coll Pharm Pract 2008, (Issue 14):20-26.
• [46]Anderson S: The state of the world's pharmacy: a portrait of the pharmacy profession. J Interprof Care 2002, 16(4):391-404. PubMed PMID: 12487847. Epub 2002/12/19. eng
• [47]Lutz EMRJ, Mattingly J, Reed BN: Pharmacy practice around the world. J Am Pharm Assoc 2009, 49(1):4-10.
• [48]Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW: Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006, 166(5):565-571.
• [49]Melchiors A, Correr C, Venson R, Pontarolo R: An analysis of quality of systematic reviews on pharmacist health interventions. Int J Clin Pharm 2012, 34(1):32-42. English
• [50]Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A: Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006, 15(1):23-31. PubMed PMID: 16456206. Pubmed Central PMCID: 2563996. Epub 2006/02/04. eng